Login / Signup

From poo to promise: Fecal microbiota transplants support immunotherapy re-sensitization in solid tumors.

Laura ChambersDennis GrencewiczDaniel Spakowicz
Published in: Cell host & microbe (2024)
Fecal microbiota transplants (FMTs) recently entered the cancer therapeutics field as a method to resensitize treatment-resistant melanoma patients to immune checkpoint inhibitors (ICIs). In this issue of Cell Host & Microbe, Kim and colleagues extend its utility to other solid tumors, including esophageal and hepatocellular carcinomas. 1 .
Keyphrases